Literature DB >> 2112191

Long-term colchicine prophylaxis in children with familial Mediterranean fever (recurrent hereditary polyserositis).

H A Majeed1, J E Carroll, F A Khuffash, Z Hijazi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2112191     DOI: 10.1016/s0022-3476(05)80667-5

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  6 in total

Review 1.  Autoinflammation: translating mechanism to therapy.

Authors:  Taylor A Doherty; Susannah D Brydges; Hal M Hoffman
Journal:  J Leukoc Biol       Date:  2011-02-17       Impact factor: 4.962

2.  Association of clinical and genetical features in FMF with focus on MEFV strip assay sensitivity in 452 children from western Anatolia, Turkey.

Authors:  Can Ozturk; Oya Halicioglu; Işil Coker; Nesrin Gulez; Sumer Sutçuoglu; Neslihan Karaca; Guzide Aksu; Necil Kutukculer
Journal:  Clin Rheumatol       Date:  2011-11-05       Impact factor: 2.980

Review 3.  Therapy of autoinflammatory syndromes.

Authors:  Hal M Hoffman
Journal:  J Allergy Clin Immunol       Date:  2009-12       Impact factor: 10.793

4.  Familial Mediterranean fever in Arab children: the high prevalence and gene frequency.

Authors:  M O Rawashdeh; H A Majeed
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

Review 5.  [Evidence-based treatment recommendations for familial Mediterranean fever : A joint statement by the Society for Pediatric and Adolescent Rheumatology and the German Society for Rheumatology].

Authors:  T Kallinich; N Blank; T Braun; E Feist; U Kiltz; U Neudorf; P T Oommen; C Weseloh; H Wittkowski; J Braun
Journal:  Z Rheumatol       Date:  2019-02       Impact factor: 1.372

6.  [Results of the systematic literature search as basis for the "Evidence-based treatment recommendations for familial Mediterranean fever patients with insufficient response or intolerability to colchicine" of the Society for Pediatric and Adolescent Rheumatology and the German Society for Rheumatology].

Authors:  T Sahr; U Kiltz; C Weseloh; T Kallinich; J Braun
Journal:  Z Rheumatol       Date:  2020-09-30       Impact factor: 1.372

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.